Vanutide Cridificar and the QS-21 Adjuvant in Japanese Subjects with Mild to Moderate Alzheimer’ s Disease: Results from Two Phase 2 Studies

Publisher: Bentham Science Publishers

E-ISSN: 1875-5828|12|3|242-254

ISSN: 1567-2050

Source: Current Alzheimer Research, Vol.12, Iss.3, 2015-03, pp. : 242-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content